Page last updated: 2024-10-15

phosphoserine and Ventricular Dysfunction, Left

phosphoserine has been researched along with Ventricular Dysfunction, Left in 1 studies

Phosphoserine: The phosphoric acid ester of serine.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sheikh, F1
Ouyang, K1
Campbell, SG1
Lyon, RC1
Chuang, J1
Fitzsimons, D1
Tangney, J1
Hidalgo, CG1
Chung, CS1
Cheng, H1
Dalton, ND1
Gu, Y1
Kasahara, H1
Ghassemian, M1
Omens, JH1
Peterson, KL1
Granzier, HL1
Moss, RL1
McCulloch, AD1
Chen, J1

Other Studies

1 other study available for phosphoserine and Ventricular Dysfunction, Left

ArticleYear
Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:4

    Topics: Actin Cytoskeleton; Actomyosin; Animals; Biomechanical Phenomena; Calcium Signaling; Cardiac Myosins

2012